Total Credits: 1 including 1 AOA Category 1-A Credit(s)
This presentation will provide an overview of the relevant evidence regarding the use of time restricted eating/intermittent fasting for the nonpharmacologic management and potential resolution of metabolic syndrome and its manifestations. In addition, the speaker will discuss practical application within an overarching treatment plan.
Objectives:
Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates is program for a maximum of 1 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.
Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611
| paredes_mw22 handout (4.72 MB) | Available after Purchase | ||
Dr. Dante Paredes is an Assistant Professor in the Department of Family Medicine and Department of Osteopathic Medicine at the University of North Texas Health Science Center. He works in the HSC Health Central Family Medicine Clinic with a clinical focus on reversing diabetes, obesity, and generalized anxiety disorder. In addition, he teaches clinical nutrition for the Texas College of Osteopathic Medicine Family Medicine Core Clerkship. He is core faculty for the Medical City of Fort Worth Family Medicine and Osteopathic Neuromuscular Medicine residencies.
Dr. Paredes discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|